🇺🇸 FDA

Drug profile · INN

nalbuphine hydrochloride

NALBUPHINE HYDROCHLORIDE

approved
US status
approved
Patents linked
2
News articles
0

Quick answer

nalbuphine hydrochloride (NALBUPHINE HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: intramuscular, intravenous, subcutaneous. Current US regulatory status: approved.

Key facts

INN nalbuphine hydrochloride
Brand NALBUPHINE HYDROCHLORIDE
Route INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Formulation INJECTABLE

Related patents

Search patents →

  1. US 12274696

    Methods of administering nalbuphine

    Expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 6525062

    Method of treating pain using nalbuphine and opioid antagonists

    Expires Mon Feb 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is nalbuphine hydrochloride?

nalbuphine hydrochloride (NALBUPHINE HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: intramuscular, intravenous, subcutaneous. Current US regulatory status: approved.

What is the brand name for nalbuphine hydrochloride?

NALBUPHINE HYDROCHLORIDE is a marketed brand name for nalbuphine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of nalbuphine hydrochloride?

nalbuphine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.